<DOC>
	<DOCNO>NCT00002924</DOCNO>
	<brief_summary>RATIONALE : Gene mutation may make prostate cancer cell unable attach androgen . This may permit growth prostate cancer . Gene test may improve identification patient advanced prostate cancer . PURPOSE : Clinical trial study androgen receptor gene patient prostate cancer responsive hormone therapy .</brief_summary>
	<brief_title>Gene Mutations Patients With Advanced Prostate Cancer That Is Not Responsive Hormone Therapy</brief_title>
	<detailed_description>OBJECTIVES : 1. feasibility collect bone marrow biopsy prostate cancer patient cooperative group set 2. incidence marrow invasion prostate tumor random bone marrow biopsy 3. influence previous prostate radiation obtain prostate tumor 4. frequency type AR mutation 5. association AR mutation response antiandrogen withdrawal .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 . Histologically proven adenocarcinoma prostate refractory hormone therapy 2 . Patients eligible anticancer therapy Protocol CLB9480 , CLB9583 , CLB9680 , CLB9780 also eligible study start treatment protocol</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>recurrent prostate cancer</keyword>
</DOC>